Anti-amyloidogenic activity of tetracyclines: studies in vitro

被引:209
作者
Forloni, G
Colombo, L
Girola, L
Tagliavini, F
Salmona, M
机构
[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
[2] Ist Neurol Nazl Carlo Besta, I-20133 Milan, Italy
关键词
Alzheimer's disease; beta-amyloid; fibrillogenesis; antibiotic; neuroprotection;
D O I
10.1016/S0014-5793(00)02380-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cerebral deposition of beta -amyloid is a major neuropathological feature in Alzheimer's disease. Here we show that tetracyclines, tetracycline and doxycycline, classical antibiotics, exhibit anti-amyloidogenic activity. This capacity was determined by the exposure of beta 1-42 amyloid peptide to the drugs followed by the electron microscopy examination of the amyloid fibrils spontaneously formed and quantified with thioflavine T binding assay. The drugs reduced also the resistance of beta 1-42 amyloid fibrils to trypsin digestion. Tetracyclines not only inhibited the beta -amyloid aggregates formation but also disassembled the pre-formed fibrils. The results indicate that drugs with a well-known clinical profile, including activity in the central nervous system are potentially useful for Alzheimer's therapy. (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:404 / 407
页数:4
相关论文
共 16 条
  • [1] Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
    Chen, M
    Ona, VO
    Li, MW
    Ferrante, RJ
    Fink, KB
    Zhu, S
    Bian, J
    Guo, L
    Farrell, LA
    Hersch, SM
    Hobbs, W
    Vonsattel, JP
    Cha, JHJ
    Friedlander, RM
    [J]. NATURE MEDICINE, 2000, 6 (07) : 797 - +
  • [2] FORLONI G, 1996, 26 ANN M SOC NEUR, V26
  • [3] ALZHEIMERS-DISEASE - THE AMYLOID CASCADE HYPOTHESIS
    HARDY, JA
    HIGGINS, GA
    [J]. SCIENCE, 1992, 256 (5054) : 184 - 185
  • [4] Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma:: Suppression leads to biochemical and pathological deposition
    Iwata, N
    Tsubuki, S
    Takaki, Y
    Watanabe, K
    Sekiguchi, M
    Hosoki, E
    Kawashima-Morishima, M
    Lee, HJ
    Hama, E
    Sekine-Aizawa, Y
    Saido, TC
    [J]. NATURE MEDICINE, 2000, 6 (02) : 143 - 150
  • [5] INTERACTION OF THE ANTHRACYCLINE 4'-IODO-4'-DEOXYDOXORUBICIN WITH AMYLOID FIBRILS - INHIBITION OF AMYLOIDOGENESIS
    MERLINI, G
    ASCARI, E
    AMBOLDI, N
    BELLOTTI, V
    ARBUSTINI, E
    PERFETTI, V
    FERRARI, M
    ZORZOLI, I
    MARINONE, MG
    GARINI, P
    DIEGOLI, M
    TRIZIO, D
    BALLINARI, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) : 2959 - 2963
  • [6] Laminin inhibits A β42 fibril formation in vitro
    Monji, A
    Tashiro, K
    Yoshida, I
    Hayashi, Y
    Tashiro, N
    [J]. BRAIN RESEARCH, 1998, 788 (1-2) : 187 - 190
  • [7] Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
    Näslund, J
    Haroutunian, V
    Mohs, R
    Davis, KL
    Davies, P
    Greengard, P
    Buxbaum, JD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (12): : 1571 - 1577
  • [8] NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773
  • [9] Inhibition of Alzheimer β-fibrillogenesis by melatonin
    Pappolla, M
    Bozner, P
    Soto, C
    Shao, HY
    Robakis, NK
    Zagorski, M
    Frangione, B
    Ghiso, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (13) : 7185 - 7188
  • [10] Translating cell biology into therapeutic advances in Alzheimer's disease
    Selkoe, DJ
    [J]. NATURE, 1999, 399 (6738) : A23 - A31